Informações:
Falhas:
ID
32867
Descrição
Shiga Progression of Diabetes, Nephropathy and Retinopathy; ODM derived from: https://clinicaltrials.gov/show/NCT00846716
Link
https://clinicaltrials.gov/show/NCT00846716
Palavras-chave
Versões (1)
- 17/11/2018 17/11/2018 -
Titular dos direitos
See clinicaltrials.gov
Transferido a
17 de novembro de 2018
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Type 2 Diabetes Mellitus NCT00846716
Eligibility Type 2 Diabetes Mellitus NCT00846716
- StudyEvent: Eligibility
Similar models
Eligibility Type 2 Diabetes Mellitus NCT00846716
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Diabetes Mellitus, Non-Insulin-Dependent
Item
type 2 diabetes mellitus
boolean
C0011860 (UMLS CUI [1])
Hemoglobin A1c measurement
Item
less than 8.0% in hba1c
boolean
C0474680 (UMLS CUI [1])
Urine albumin/creatinine ratio measurement
Item
less than 300 mg/g cr of urinary albumine level
boolean
C0455271 (UMLS CUI [1])
Sulfonylurea | Biguanide
Item
concomitant therapy with su and/or biguanide
boolean
C0038766 (UMLS CUI [1])
C0005382 (UMLS CUI [2])
C0005382 (UMLS CUI [2])
Hypertensive disease Untreated | Hypertensive disease | Angiotensin II receptor antagonist | Angiotensin-Converting Enzyme Inhibitors
Item
untreated hypertension and hypertension treated with arb or acei
boolean
C0020538 (UMLS CUI [1,1])
C0332155 (UMLS CUI [1,2])
C0020538 (UMLS CUI [2])
C0521942 (UMLS CUI [3])
C0003015 (UMLS CUI [4])
C0332155 (UMLS CUI [1,2])
C0020538 (UMLS CUI [2])
C0521942 (UMLS CUI [3])
C0003015 (UMLS CUI [4])
Heart failure
Item
history of heart failure and concomitant heart failure
boolean
C0018801 (UMLS CUI [1])
Thiazolidinediones
Item
history of administration of tzd agent
boolean
C1257987 (UMLS CUI [1])
Liver Dysfunction Severe | Aspartate aminotransferase increased | Alanine aminotransferase increased
Item
severe hepatic dysfunction with more than 3 times higher than upper limit of normal range of got, gpt or rgpt
boolean
C0086565 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0151904 (UMLS CUI [2])
C0151905 (UMLS CUI [3])
C0205082 (UMLS CUI [1,2])
C0151904 (UMLS CUI [2])
C0151905 (UMLS CUI [3])
Renal dysfunction Severe | Serum creatinine raised
Item
severe renal dysfunction with more than 2.5 of cr
boolean
C3279454 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0700225 (UMLS CUI [2])
C0205082 (UMLS CUI [1,2])
C0700225 (UMLS CUI [2])
Adverse events Thiazolidinediones Related
Item
history of ae with tzd agent
boolean
C0877248 (UMLS CUI [1,1])
C1257987 (UMLS CUI [1,2])
C0439849 (UMLS CUI [1,3])
C1257987 (UMLS CUI [1,2])
C0439849 (UMLS CUI [1,3])
Insulin regime
Item
insulin treatment
boolean
C0557978 (UMLS CUI [1])
Urinary tract infection
Item
concomitant urinary track infection
boolean
C0042029 (UMLS CUI [1])